Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil

Brazilian Journal of Medical and Biological Research

Volumn 39, Issue 5, 2006, Pages 595-602

  Silva, L K ^a   Silva, M B S ^a   Rodart, I F ^a   Lopes, G B ^a   Costa, F Q ^a   Melo, M E ^b   Gusmao F ^c   Reis, Miter G ^a,b,d  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c Comissão Estadual de Nefrologia ^*  (Brazil)

^d ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

Author keywords

Brazil; Genotype; Hemodialysis; Hepatitis C; Seroprevalence; Viremia

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; BRAZIL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; QUALITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEROPREVALENCE; TRANSFUSION; VIRUS DETECTION; VIRUS GENE; VIRUS TRANSMISSION; VIRUS VIRULENCE;

HEPATITIS C VIRUS; MUREX; RNA VIRUSES;

EID: 33646428641     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2006000500005     Document Type: Article

References (40)

1. Choo OL, Kuo G, Weiner AJ et al. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244: 359-362.
2. Hoofnagle JH (1997). Hepatitis C: the clinical spectrum of disease. Hepatology, 26: 15S-20S.
3. Simmonds P, Holmes EC, Cha TA et al. (1993). Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. Journal of General Virology, 74: 2391-2399.
4. Santana GO, Cotrim HP, Mota E et al. (2001). Antibodies to hepatitis C virus in patients undergoing hemodialysis in Salvador, BA, Brazil. Arquivos de Gastroenterologia, 38: 24-31.
5. Carneiro MA, Martins RM, Teles SA et al. (2001). Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. Memórias do Instituto Oswaldo Cruz, 96: 765-769.
6. Busek SU, Babe EH, Tavares Filho HA et al. (2002). Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil. Memórias do Instituto Oswaldo, Cruz, 97: 775-778.
7. Vanderborght BO, Rouzere C, Ginuino CF et al. (1995). High prevalence of hepatitis C infection among Brazilian hemodialysis patients in Rio de Janeiro: a one-year follow-up study. Revista do Instituto de Medicina Tropical de São Paulo, 37: 75-79.
8. Góngora DVN (1998). Marcadores sorológicos da infecção pelo vírus da hepatite C em trabalhadores a pacientes da Unidade de Diálise do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo. Revista da Sociedade Brasileire de Medicina Tropical, 31: 585-586.
9. Karohl C, Manfro RC, Sanger MB et al. (1995). Prevalência de anticorpos antivírus da hepatite C em pacientes em hemodiálise crônica de Porto Alegre. Jornal Brasileiro de Nefrologia, 17: 40-46.
10. Oliveira ML, Bastos FI, Sabino RR et al. (1999). Distribution of HCV genotypes among different exposure categories in Brazil. Brazilian Journal of Medical and Biological Research, 32: 279-282.
11. Djukanovic L, Radovic M, Bakovic J et al. (2002). Epidemiology of end-stage renal disease and current status of hemodialysis in Yugoslavia. International Journal of Artificial Organs, 25: 852-859.
12. Sivapalasingam S, Malak SF, Sullivan JF et al. (2002). High prevalence of hepatitis C infection among patients receiving hemodialysis at an urban dialysis center. Infection Control and Hospital Epidemiology, 23: 319-324.
13. Yamaji K, Hayashi J, Kawakami Y et al. (1996). Long term survey of hepatitis C virus infection in hemodialysis units in Fukuoka, Japan. Journal of Epidemiology, 6: 166-171.
14. Allander T, Medin C, Jacobson SH et al. (1994). Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. Journal of Medical Virology, 43: 415-419.
15. Bassit L, Van Heuverswyn H, De Bosschere K et al. (2002). Comparative study of two anti-HCV screening tests in a large genotyped population of Brazilian dialysis patients. European Journal of Clinical Microbiology and Infectious Diseases, 21: 404-406.
16. Caramelo C, Bartolome J, Albalate M et al. (1996). Undiagnosed hepatitis C virus infection in hemodialysis patients: value of HCV-RNA and liver enzyme levels. Kidney International, 50: 2027-2031.
17. Silini E, Bono F, Cividini A et al. (1995). Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology, 21: 285-290.
18. Benvegnu L, Pontisso P, Cavalletto D et al. (1997). Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology, 25: 211-215.
19. Kohara M, Tanaka T, Tsukiyama-Kohara K et al. (1995). Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics. Journal of Infectious Diseases, 172: 934-938.
20. Masukawa A, Miyachi H, Ohshima T et al. (1997). Monitoring of inhibitors of the polymerase chain reaction for the detection of hepatitis C virus using the positive internal control. Rinsho Byori, 45: 673-678.
21. Sambrook J, Fritsch EF & Maniatis T (1989). Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press, New York.
22. Chan SW, McOmish F, Holmes EC et al. (1992). Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. Journal of General Virology, 73: 1131-1141.
23. Davidson F, Simmonds P, Ferguson JC et al. (1995). Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. Journal of General Virology, 76: 1197-1204.
24. McOmish F, Yap PL, Dow BC et al. (1994). Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. Journal of Clinical Microbiology, 32: 884-892.
25. Abramson JH & Gahlinger PM (2001). Computer Programs for Epidemiologic Analyses: PEPI Version 4.0. [http://sagebrushpress.com/pepibook.html]. Accessed December 9, 2004.
26. Carrilho FJ, Moraes CR, Pinho JR et al. (2004). Hepatitis B virus infection in Haemodialysis Centres from Santa Catarina State, Southern Brazil. Predictive risk factors for infection and molecular epidemiology. BMC Public Health, 4: 13.
27. Cendoroglo Neto M, Draibe SA, Silva AE et al. (1995). Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrology, Dialysis, Transplantation, 10: 240-246.
28. Calabrese G, Vagelli G, Guaschino R et al. (1991). Transmission of anti-HCV within the household of haemodialysis patients. Lancet, 338: 1466.
29. Harmankaya O, Cetin B, Obek A et al. (2002). Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation? Renal Failure, 24: 639-644.
30. Silva LK, Parana R, Souza SP et al. (2000). Hepatitis C virus genotypes in a northeastern area of Brazil. American Journal of Tropical Medicine and Hygiene, 62: 257-260.
31. Fabrizi F, Martin P, Dixit V et al. (2000). Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. American Journal of Kidney Diseases, 35: 122-129.
32. Mizuno M, Higuchi T, Yanai M et al. (2002). Dialysis-membrane-dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis. Nephron, 91: 235-242.
33. Mazur W, Mazurek U, Jurzak M et al. (2001). Positive and negative strands of HCV-RNA in sera and peripheral blood mononuclear cells of chronically hemodialyzed patients. Medical Science Monitor, 7: 108-115.
34. Schmidt WN, Wu P, Cederna J et al. (1997). Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests. Journal of Infectious Diseases, 176: 27-33.
35. Saback FL, Gomes SA, de Paula VS et al. (1999). Age-specific prevalence and transmission of TT virus. Journal of Medical Virology, 59: 318-322.
36. Sarrazin C (2002). Highly sensitive hepatitis C virus RNA detection methods: molecular backgrounds and clinical significance. Journal of Clinical Virology, 25 (Suppl 3): S23-S29.
37. Sarrazin C, Teuber G, Kokka R et al. (2000). Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology, 32: 818-823.
38. Florentino GSA (2004). Discordaância entre os métodos de biologia molecular e ELISA no diagnóstico da hepatite C em pacientes hemodializados [Discordance between molecular biologic methods and ELISA in the diagnosis of hepatitis C in hemodialysis patients]. Master's thesis, Pós-graduaçãco em Medicina, Universidade Federal da Bahia, Salvador, BA, Brazil.
39. Fabrizi F, Martin P, Dixit V et al. (1999). Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. American Journal of Nephrology, 19: 383-388.
40. Moreira R, Pinho JR, Fares J et al. (2003). Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV-RNA and antibodies. Canadian Journal of Microbiology, 49: 503-507.